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Cellular/Molecular
Inhibitory Control of Synaptic and Behavioral Plasticity by
Octopaminergic Signaling
Alex C. Koon and Vivian Budnik
Department of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605
Adrenergic receptors and their ligands are important regulators of synaptic plasticity and metaplasticity, but the exact mechanisms
underlying their action are still poorly understood. Octopamine, the invertebrate homolog of mammalian adrenaline or noradrenaline,
plays important roles in modulating behavior and synaptic functions. We previously uncovered an octopaminergic positive-feedback
mechanism to regulate structural synaptic plasticity during development and in response to starvation. Under this mechanism, activa-
tion of Octß2R autoreceptors by octopamine at octopaminergic neurons initiated a cAMP-dependent cascade that stimulated the devel-
opment of new synaptic boutons at the Drosophila larval neuromuscular junction (NMJ). However, the regulatory mechanisms that
served to brake such positive feedbackwere not known.Here, we report the presence of an alternative octopamine autoreceptor, Octß1R,
with antagonistic functions on synaptic growth. Mutations in octß1r result in the overgrowth of both glutamatergic and octopaminergic
NMJs, suggesting that Octß1R is a negative regulator of synaptic expansion. AsOctß2R, Octß1R functioned in a cell-autonomousmanner
at presynaptic motorneurons. However, unlike Octß2R, which activated a cAMP pathway, Octß1R likely inhibited cAMP production
through inhibitory Go. Despite its inhibitory role, Octß1R was required for acute changes in synaptic structure in response to octo-
pamine and for starvation-induced increase in locomotor speed. These results demonstrate the dual action of octopamine on synaptic
growth and behavioral plasticity, and highlight the important role of inhibitory influences for normal responses to physiological stimuli.
Introduction
Adrenaline/noradrenaline and their receptors have emerged as
important modulators of synaptic plasticity, metaplasticity, and
behavior in the mammalian brain (Murchison et al., 2004; Hu et
al., 2007; Kuzmiski et al., 2009). However, the mechanisms un-
derlying this regulation of synaptic structure are not known.
In insects, adrenergic signaling is accomplished through octo-
pamine and octopamine receptors (Balfanz et al., 2005) and is a
powerful modulator of behaviors such as appetitive behavior
(Long and Murdock, 1983; Suo et al., 2006) and aggression
(Hoyer et al., 2008; Zhou et al., 2008). It also regulates synaptic
function (Breen and Atwood, 1983) and synaptic structure
(Koon et al., 2011).
We have previously demonstrated that at theDrosophila larval
neuromuscular junction (NMJ) octopamine regulates the expan-
sion of bothmodulatory and excitatory nerve terminals (Koon et
al., 2011). Larval NMJs are innervated by glutamatergic, octo-
paminergic, and peptidergic motorneurons (Prokop, 2006). Of
these, glutamatergic nerve terminals provide classical excitatory
transmission (Jan and Jan, 1976), while octopaminergic nerve
endings support global modulation of excitability and synaptic
growth (Monastirioti et al., 1995; Koon et al., 2011). Larval NMJs
are continuously expanding to compensate for muscle cell
growth (Schuster et al., 1996) and respond to acute changes in
activity by extending new synaptic boutons (Ataman et al., 2008;
Koon et al., 2011). We previously demonstrated that, by binding
to the octopamine autoreceptor Octß2R, octopamine activated a
cAMP second messenger pathway that led to CREB activation
and transcription, which in turn promoted the extension of new
octopaminergic nerve endings (Koon et al., 2011). This positive-
feedback mechanism was required for an increase in locomotor
activity in response to starvation. In addition, this mechanism
positively regulated the growth of glutamatergic nerve endings
through Octß2R receptors present in glutamatergic neurons. An
important question regards the mechanisms that serve to brake
such positive feedback.
Here, we demonstrate the presence of a second octopamine
receptor, Octß1R, which serves as such a brake. We show that
Octß1R is also an autoreceptor in octopaminergic neurons that
serves to inhibit synaptic growth. This inhibitory influence is
excerpted through the activation of the inhibitoryG-protein sub-
unit, Go, and thus by limiting cAMP production. Like Octß2R
receptors, Octß1R receptors are also present at excitatory gluta-
matergic endings. Thus, octopamine release induces a dual excit-
atory (through Octß2R) and inhibitory (through Octß1R)
function on the growth of both octopaminergic and glutamater-
gic endings. The presence of both the excitatory and inhibitory
receptors is required for normal structural plasticity at octo-
paminergic terminals and for normal responses to starvation, as
Received Dec. 30, 2011; revised Feb. 20, 2012; accepted March 12, 2012.
Author contributions: A.C.K. and V.B. designed research; A.C.K. performed research; A.C.K. and V.B. analyzed
data; A.C.K. and V.B. wrote the paper.
This work was supported by NIH Grant R01 MH070000 (V.B.). We thank Dr. James Ashley for thoughtful com-
ments on this manuscript, and Ceren Korkut for her help on some studies. We also thank Dr. Bulent Ataman and Dr.
Comert Kural for their assistance in acquiring the reagents for generating the octß1r mutant, and Dr. Andrew
Tomlinson for sending us the go007mutant.
The authors declare no competing financial interests.
Correspondence should be addressed to Vivian Budnik, Department of Neurobiology, LRB, University of Massa-
chusettsMedical School, 364Plantation Street,Worcester,MA01605-2324. E-mail: vivian.budnik@umassmed.edu.
DOI:10.1523/JNEUROSCI.6517-11.2012
Copyright © 2012 the authors 0270-6474/12/326312-11$15.00/0
6312 • The Journal of Neuroscience, May 2, 2012 • 32(18):6312–6322
obliterating Octß1R (this study) or Octß2R (Koon et al., 2011)
prevents the acute growth of octopaminergic ending in response
to octopamine and the increase in locomotor speed in response to
starvation. Thus, this study highlights the requirement of both
excitatory and inhibitory influences for normal synaptic and be-
havioral plasticity.
Materials andMethods
Fly strains. Flies were reared in standardDrosophilamedium at 25°C except
where indicated. Both males and female larvae were used in these studies.
Animals used in RNAi experiments were reared at 29°C to increase knock-
down efficiency but were incubated at 25°C for 1 h before experiments. The
following stocks were used: the wild-type strain Canton-S (CS), Tdc2-Gal4
(Bloomington Stock Center, Bloomington, IN), C380-Gal4 (Budnik et al.,
1996), BG439-Gal4 (Koon et al., 2011), 19H07-Gal4, 20C11-Gal4, 20E11-
Gal4, 21E03-Gal4 (Pfeiffer et al., 2008), UAS-mCD8-GFP (Bloomington),
UAS-PTX (Ferris et al., 2006), y dncM14 cv v f (Bloomington), UAS-Dnc
(remobilized to the second chromosome) (Cheung et al., 1999), rut2080
(Bloomington), go007 (Fre´mion et al., 1999), UAS-Dcr2 (Bloomington),
PBac{WH}oa2[f02819] (Bloomington), PBac{WH}w[f06195] (Harvard
Exelixis, Cambridge, MA), PBac{WH}Octß2R[f05679] (Bloomington),
w[1118]; Df(3R)Exel6191, P{w[mC]XP-U}Exel6191 (Bloomington),
UAS-Octß1R-RNAi (110537; Vienna Drosophila RNAi Center, Vienna,
Austria), UAS-Go-RNAi (110552 and 19124; Vienna Drosophila RNAi
Center) (110552 isGo-RNAi1 and19124 isGo-RNAi2),UAS-Gi-RNAi
(28510;ViennaDrosophilaRNAiCenter; JF01608;TransgenicRNAiProject,
Harvard Medical School, Cambridge, MA) (28510 is Gi-RNAi1 and
JF01608 is Gi-RNAi2).
Generation and analysis of oct1r mutants. oct1r mutants were gen-
erated using PBac{WH}oa2[f02819] and PBac{WH}w[f06195], which
contain piggyback-based transposons in the same orientation on the
third chromosome. A heat shock Flipase was crossed into the first chro-
mosome to induce recombination between the two transposons and to
excise the flanked DNA. The heat shock processes were performed twice
during development at 37°C for 30 min each (once during first-instar
and once during second-instar larval stages, respectively). To obtain a
stable mutant, the X-chromosome containing the heat shock Flipase was
then crossed out and substituted with an X-chromosome in thew- back-
ground. Genomic PCR was performed to verify the desired deletion.
Primers used to verify the deletion were GTCATGCGGCACCG-
GAAATTG (5 genomic primer) paired with CCTCGATATACAGAC-
CGATAAAAC (WH3) (to verify the presence of the 3 end of
PBac[f02819]) and CTAAAGTGCATTGCACCTGG (3 genomic
primer) paired with TCCAAGCGGCGACTGAGATG (WH5) (to verify
the 5 end of PBac[f06195]). Negative control primers against deleted
Oct1R genomic sequence were ACAGGAGCGTCTGGTGTAC paired
with CGGAGTGATGCAACTATCGC, TGTCAAGCGCACAGAACTC
paired with GCGTTGGTTGGTTCCAAGG, and AGTGCTGTACAG-
TAGCGAGC paired with CCTGACTCCATGACACCTAAATATG.
Primers used to verify the presence of PBac{WH}Octß2R[f05679] in
oct1r, oct2r double mutant were CGCAGGTCATGGAGAGTGTG
and WH5. RT-PCR was performed by extracting total mRNA from
dissected larval body wall muscles and larval brains using a combination
of Trizol (Invitrogen) and the RNeasy kit (QIAGEN). Synthesis of cDNA
forRT reactions was performed using the Superscript III kit (Invitro-
gen), where RT reactions lacked reverse transcriptase. The RT and
RT reactions were then used for PCR using forward primer CCGC-
CTGGCAACGAGTAAC and reverse primer CTCGTCGATGAGC-
CCGTC. These primers were specifically designed to recognize all known
splice variants of Octß1R, and across an exon–intron junction to avoid
false signal from any contaminating genomic DNA.
Immunocytochemistry. Larval body wall muscles were dissected and
fixed for 15 min in 4% paraformaldehyde. For tyramine--hydroxylase
(TBH) immunocytochemistry, samples were fixed in Bouin’s fixative.
Antibodies and their concentrations were as follows: anti-TBH, 1:400
(Koon et al., 2011); anti-HRP-Dylite594, 1:500 (Jackson ImmunoRe-
search). Secondary antibodies conjugated to either FITC or Dylite594
(Jackson ImmunoResearch) were used at a concentration of 1:200. Im-
aging of fixed preparations was described previously (Ataman et al.,
2008).
Animal rearing conditions for synaptopod analysis. All animals used in
synaptopod analysis carried a copy of Tdc2-Gal4 and a copy of UAS-
mCD8-GFP to visualize the type II terminals. Egg collection was done in
standard 25-mm-diameter cornmeal/agar/molasses food vials at 25°C
with60% humidity. Larvae were grown at low density. Wandering late
third-instar larvae were used for experiments.
Animal rearing conditions for RNAi experiments. All animals used in
RNAi experiments carried a copy of UAS-Dcr2. Egg collection was done
at 29°C instead of 25°C to increase RNAi efficiency. For behavioral ex-
periments, food vials rearing animals at 29°C were incubated at 25°C for
1 h before crawling assay or starvation assay.
Stimulation procedures and live imaging of dissected preparations. Syn-
aptopods were imaged from live preparations as described by Koon et al.
(2011). For octopamine stimulation, larvae were dissected in HL3 saline
(Stewart et al., 1994) containing 0.1 mM Ca2 and preparations gently
glued onto a custom-made glass imaging chamber using surgical glue.
Then, identified NMJs were imaged on an Improvision spinning disc
confocalmicroscope (PerkinElmer)with aC9100-13Hamamatsu cooled
EM-CCD camera and using a 40, 1.2 NA objective, with a 2.4 optical
zoom. After imaging for 30 min, animals were partially unglued to
allowmuscles to contract freely, and 10M octopamine in HL3 contain-
ing 1.5 mMCa2was then applied for 15min followed by five washes for
15 min each with 0.1 mM Ca2 HL3 saline before imaging again. For
experiments involving pertussis toxin (PTX) application, dissected living
larval prep was preincubated in HL3 containing 0.1 mM Ca2, 0.03%
DMSO, 30 M ATP, and 1.5 g/ml PTX (purchased from Sigma-
Aldrich) for 2 h. Then,HL3 containing 1.5mMCa2, 10Moctopamine,
0.03% DMSO, 30 M ATP, and 1.5 g/ml PTX was applied for 15 min,
followed by five washes for 15 min each with the preincubation HL3.
Control animals were preincubated, stimulated, and washed in the same
way but without PTX.
Crawling assay and starvation assay.Details of crawling and starvation
assays were described by Koon et al. (2011). Synchronized mid-third-
instar larvae were washed with water, and individually loaded onto a 3%
agar plate. Animals were allowed a pre-run of 25 s on the agar before
manual recordings weremade for 1min. Experiments were performed in
a 25°C, 60% humidity behavioral room under red light. For starvation
assays, larvae were maintained in food or food-free moisturized 35 mm
Petri dishes for 2 h, and then subjected to the crawling assay. For behav-
ioral assays, N represents number of animals.
Quantification of boutons and synaptopod number. Type I boutons
number was obtained atmuscles 6 and 7 of abdominal segment A3, while
type II bouton number was quantified at muscle 12 in A3. For muscle
areameasurements, themuscle length andwidthweremeasured using an
ocular scale bar. Measurements of synaptopod number were from mus-
cles 12 of segment A4 in dissected preparations. Number of synaptopods
in the histograms represents the total number of synaptopods per 100
m of each arbor. Synaptopods were defined as such if they measured at
least 0.5 m in length and at most 0.5 m in width. For morphometric
analysis of NMJs, N represents the number of NMJs analyzed (at most
two per animal).
Statistical analysis. For comparisons between more than two sample
groups, an ANOVA with Tukey’s post hoc test was performed. For pair-
wise comparisons, Student’s t test was used. The numbers in histograms
represent mean  SEM. ***p   0.0001; **p   0.001; *p  0.05.
Unless otherwise noted, sample number (N) represents the number of
NMJs for anatomical measurements, or the number of animals for be-
havioral analyses. Statistical analysis for animals reared at 25 or 29°C was
done separately.
Genotype abbreviations. Type I motorneuron driver control is BG439/
and BG439	Dcr2 for RNAi experiments. Type IImotorneuron driver con-
trol is Tdc2/ and Tdc2	Dcr2 for RNAi experiments. Type III motor-
neuron driver control is C380/ and C380	Dcr2 for RNAi experiments.
[Transgene]-typeI is BG439	[Transgene] and BG439	[Transgene],Dcr2
for RNAi experiments. [Transgene]-typeII is Tdc2	[Transgene] and
Tdc2	[Transgene],Dcr2 for RNAi experiments. [Transgene]-typeIII is
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C380	[Transgene] and C380	[Transgene],Dcr2 for RNAi experiments,
unless otherwise indicated.
Results
Octß1R receptors are present in motorneurons
We have recently demonstrated that octopamine-containing
synaptic terminals (type II terminals) undergo structural changes
in response to behavioral states that induce an increase in loco-
motion (Koon et al., 2011). Underlying this structural change is
the activation of a positive-feedback mechanism, in which octo-
pamine release, presumably by type II octopaminergic synaptic
boutons, activates Octß2R autoreceptors (Koon et al., 2011). In
turn, Octß2R turns on a cAMP- and CREB-dependent signaling
cascade at octopaminergic neurons, which induces synaptic ex-
pansion. This positive control mechanism not only promotes the
proliferation of type II synaptic boutons but also functions in a
paracrine fashion to stimulate the growth of type I boutons
(Koon et al., 2011), primarymediators of excitatory transmission
at the NMJ.
Analysis of the Gal4 transcriptional reporters, 19H07-Gal4,
21E03-Gal4, 20C11-Gal4, and 20E11-Gal4, generated by fusing
Gal4 to four different intronic regions of theOctß1R (also known
as OA2) octopamine receptor inDrosophila (Pfeiffer et al., 2008)
(Fig. 1 I) revealed that reporter (mCD8-GFP) signal could be
observed in all bouton types, including type I and type II boutons,
but not in postsynaptic muscles (Fig. 1A–D). The intensity of the
reporter signal varied among the different strains or was present
in only a subset of bouton types. For example, 19H07-Gal4 dis-
playedmCD8-GFP signal primarily in type Ib nerve endings, very
Figure 1. Expression of Octß1R-Gal4 transcriptional reporters at the NMJ.A–D, NMJs atmuscle 12 of third-instar larvae expressingmCD8-GFP using four different Octß1R-Gal4 strains generated
from different intronic regions of the octß1r locus (Pfeiffer et al., 2008). NMJs were double labeled with anti-GFP (green) and anti-HRP (red). The panels represent confocal Z-stack projections. As
shown by the white arrowheads, reporter expression is found in the following synaptic endings: 19H07-Gal4: type Ib and type II (A1–3); 21E03-Gal4: type Is and type II (B1–3); 20C11-Gal4: type
III (C1–3); 20E11-Gal4: type Ib and type Is (D1–3). E, F, Reporter gene expression in the CNS and imaginal discs of 19H07-Gal4, showing reporter expression in the CNS and proximal band of retinal
cells in the optic disc (E); 21E03-Gal4, showing signal in the CNS and edge of imaginal discs (F ); 20C11-Gal4: CNS, showing GFP signal in differentiated retinal cells at the optic disc, one to two cells
in other imaginal discs, and neurons innervating the pharyngeal muscles (inset) (G); 20E11-Gal4, showing Gal4 expression in the CNS (H ). Scale bar: A–D, 20m; E–H, 240m; G, inset, 70m.
I, Schematic representationof theoctß1rgenomic region, showingpredictedalternatively spliced isoformsA–C, and theapproximate locations (brackets) of different intronic regionsused togenerate theGal4
transcriptional reporters(Pfeifferetal.,2008).TheapproximatelocationofthetwoPBac insertionsusedtogeneratetheoctß1rmutant isshownwithbluearrowheads.Orangeboxes,Codingregionwithinexons.
Gray boxes, Noncoding regionswithin exons (UTRs). Black lines, Introns. J, RT-PCR fromwild-type and octß1rmutant RNA. Virtually no expression of the remaining fragment in octß1rmutantswas observed,
indicating that themutant is likely a nullmutant.RT, Reverse transcription reactionswith reverse transcriptase added;RT, reverse transcriptase absent.
6314 • J. Neurosci., May 2, 2012 • 32(18):6312–6322 Koon and Budnik • Octopaminergic Control of Synaptic Plasticity
weak signal in type II terminals, and no detectable signal in type Is
and type III terminals (Fig. 1A). 21E03-Gal4 showed strong sig-
nal in type Is and type II boutons, but the signal was not detected
in type Ib and type III endings (Fig. 1B). 20C11-Gal4 had strong
mCD8-GFP expression in type III endings, but no signal was
observed in type I or type II terminals (Fig. 1C). Finally, 20E11-
Gal4 had weak reporter signal in type Ib boutons, barely detect-
able signal in type Is boutons, and undetectable signal in type II
and type III boutons. Most importantly, these results suggest
that, like Octß2R, Octß1R is also expressed in motorneurons.
Apart frommotorneurons, the aboveGal4 lines also displayed
reporter gene expression in the CNS and imaginal discs. 19H07-
Gal4 had weak reporter signal in the brain lobes, strong signal in
a few neurons per segment in the ventral ganglion, and signal in a
proximal band of retinal cells in the optic disc (Fig. 1E). 21E03-
Gal4 demonstratedGFP reporter expression in several cells in the
brain, as well as in octopaminergic motorneurons in the ventral
ganglion (Fig. 1F). In addition, a strong GFP band at one edge of
each imaginal disc was observed (Fig. 1F). 20C11-Gal4 displayed
GFP reporter expression in many neurons of the brain and ven-
tral ganglion (Fig. 1G). In addition, strong label was observed in
differentiated retinal cells in the optic disc, in one to two cells per
imaginal disc (Fig. 1G), and in neurons innervating the pharyn-
geal muscles (Fig. 1G, inset). Finally, 20E11-Gal4 had broad re-
porter signal inmany cells of the larval brain and ventral ganglion
(Fig. 1H). Although we attempted to verify the above pattern of
reporter gene expression by raising anti-Octß1R antibodies, these
efforts were unsuccessful. Nevertheless, a recent study reported
the pattern of Octß1R expression using in situ hybridization, and
reported the distribution of receptor transcript in the CNS, ima-
ginal discs, and salivary glands (Ohhara et al., 2012).
To determine whether Octß2R andOctß1R served redundant
roles at the NMJ, we generated an octß1r mutant by FRT-
mediated recombination of two P-element insertions
(PBac[WH]oa2[f02819] and PBac[WH]w[f06195]) (Fig. 1 I).
The recombination was verified by genomic PCR. Analysis of the
mutant strain demonstrated thatmost of the octß1r coding region
had been removed, excluding a fragment encompassing the 5-
UTR and the first exon of Octß1R, which is predicted to encode
the N-terminal extracellular domain, the first transmembrane
domain, and 4 aa of the first intracellular loop of the receptor.
However, RT-PCR demonstrated the virtual absence of the pre-
dicted transcript fragment (Fig. 1 J), suggesting that octß1r is
likely a null mutant. No other known genes were disrupted by the
excision.
Octß1R receptors are negative regulators of synaptic growth
We previously demonstrated that octopaminergic type II NMJs ex-
pand by extending “natural synaptopods,” motile filopodia-like ex-
tensions observed during the expansion of type II terminals through
larval development (Koon et al., 2011). Furthermore, we found that
thenumberofnatural synaptopods is reduced inoctß2rmutantsdue
to an autonomous function of Octß2R in octopaminergic neurons
(Koon et al., 2011). To determine whether Octß1R receptors had a
redundant role in type II boutons, we examined natural synapto-
pods in octß1rmutants by expressing mCD8-GFP in octopaminer-
gic neurons using the Tdc2-Gal4 driver, which drives Gal4
expression in these neurons (Cole et al., 2005).Notably, the number
of natural synaptopods was substantially increased in this mutant
(Fig. 2A–C), in complete opposition to the phenotype found in
octß2rmutants.Asimilarphenotypewas foundwhenOctß1Rrecep-
torwasdownregulated inoctopaminergicneurons aloneby express-
Figure 2. octß1r mutants display an overgrowth of octopaminergic endings at the NMJ. A, B, Confocal Z-stack projections of type II arbors at muscle 12 in larvae expressing mCD8-GFP in
octopaminergic neurons of control (A) and octß1r mutant (B), showing a marked increase in the number of natural synaptopods (white arrows). C, Quantification of the number of natural
synaptopods per 100mof type II arbor in octß2rmutants, octß1rmutants, and animals expressingOctß1R-RNAi in type IImotorneurons, showing increasednatural synaptopods in octß1rmutants
and Octß1R-RNAi animals [N (left to right) 175, 13, 21, 10, 11, 25, 17 NMJs].D, E, Third-instar larval NMJs atmuscles 12 of wild-type (D) and octß1rmutant (E), showing amarked increase in the
number of type II boutons (shown by TBH labeling). NMJs were double labeled with anti-TBH (green) and anti-HRP (red). The panels represent confocal Z-stack projections. F, Quantification of the
number of type II boutons at muscle 12 in octß2rmutants, octß1rmutants, and animals expressing Octß1R-RNAi in type II motorneurons, showing increased type II boutons in octß1rmutants and
Octß1R-RNAi animals [N (left to right)22, 17, 15, 11, 16, 20, 11NMJs]. Animals used inRNAi experimentswere reared at 29°C to increase knockdownefficiency. Scale bar:A,B, 8m;D,E, 20m.
Error bars indicate SEM. ***p 0.0001; **p 0.001; *p 0.05.
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ing Octß1R-RNAi in these neurons (Fig.
2C), suggesting a cell-autonomous function
of the receptor. Thus, Octß1R receptors ap-
pear to negatively regulate the formation of
synaptopods at type II terminals.Consistent
with this role, thenumberof type II boutons
was also increased both in octß1r mutants
and in larvae expressing Octß1R-RNAi in
octopaminergic neurons (Fig. 2D–F).
The inhibitory function of Octß1R is
likely mediated by Go
Synaptopod formation is downstream of ele-
vated cAMP levels mediated by octopamine-
dependent activationofOctß2Rs (Koonet al.,
2011), aG-protein-coupled receptor.Octß1R
is also predicted to function as a G-protein-
coupled receptor (Balfanz et al., 2005; Evans
andMaqueira,2005).Thereforewewondered
whether thenegative regulationof type II syn-
aptic growth by Octß1R could be mediated
through activation of G-protein inhibi-
tory subunits, such as Go or Gi
(El-Armouche et al., 2003; Johnston and
Watts, 2003). This hypothesis was first ex-
amined by bath applying PTX, which in
Drosophila specifically inhibits Go
(Thambi et al., 1989), and determining its
consequences on octopamine-dependent
synaptopod formation. As previously re-
ported, application of 10 M octopamine
to wild-type control NMJs resulted in a
significant increase in the number of syn-
aptopods (Fig. 3A,C). Application of 10
M octopamine in conjunction with 1.5
g/ml PTX significantly enhanced this ef-
fect (Fig. 3B,C). This is consistent with
the idea that activation of Go partially
inhibits octopamine-dependent synapto-
pod formation. In support of this inter-
pretation, the number of natural
synaptopods was substantially increased
in larvae expressing UAS-PTX in octo-
pamine neurons throughout larval devel-
opment (Fig. 3D,E,G).
To corroborate an involvement of Go
in inhibiting synaptopod formation, we ex-
pressed two differentGo-RNAi constructs
in octopaminergic neurons, Go-RNAi1
and Go-RNAi2, and examined the num-
ber of natural synaptopods at type II arbors
in third-instar larvae. In agreementwithour
model,downregulatingGobyeitherRNAi
resulted in significant increase in the num-
ber of natural synaptopods (Fig. 3F,G). In
contrast, downregulating Gi by using two
different Gi-RNAi constructs was without
effect (Fig. 3G).
Since synaptopods are precursors of
type II boutons (Koon et al., 2011), we
also expected that inhibiting or down-
regulating Go function should result in
increased type II bouton growth. Indeed,
Figure 3. Disruption of Go phenocopies synaptic overgrowth of octß1r. A, B, Confocal Z-stack projections of type II arbors at
muscle 12 in larvae expressing mCD8-GFP in octopaminergic neurons before and after bath application of octopamine. A, Bath
application of octopamine increases the number of synaptopods on type II arbors (white arrowheads). B, Bath application of
octopamine in the presence of PTX results in significantly larger increase of synaptopods than octopamine alone (white arrow-
heads). C, Quantification of the net increase of synaptopods in A and B per 100m of type II arbor, showing that octopamine
induces a larger increase in synaptopods in larval preparations with 2 h PTX incubation than preparations without PTX treatment
[N (left to right)18, 13, 16NMJs].D–F, Confocal Z-stackprojections of type II arbors atmuscle 12 in larvae expressingmCD8-GFP
in octopaminergic neurons of control (D), animals expressing PTX in type II (E), and animals expressing Go-RNAi1 in type II (F ),
showing a marked increase in the number of natural synaptopods (white arrowheads). G, Quantification of natural synaptopods
per 100mof type II arbor in animals expressing PTX, Go-RNAi, or Gi-RNAi in type II, showing that that the disruption of Go
function but not Gi results in increased number of natural synaptopods [N (left to right) 175, 12, 25, 19, 10, 11, 10 NMJs].
Animals used in RNAi experiments were reared at 29°C to increase knockdown efficiency. H, Quantification of type II boutons at
muscle 12 in animals expressing PTX, Go-RNAi, or Gi-RNAi in type II motorneurons alone or type III motorneurons, showing
that that the disruption of Go function but not Gi results in increased number of type II boutons. [N (left to right) 22, 16, 12,
20, 24, 16, 16, 10, 16 NMJs]. I, Quantification of natural synaptopods per 100m of type II arbor in octß1r mutants, octß1r/
heterozygotes, go007/ heterozygotes, and go007/; octß1r/ transheterozygotes, showing that go007/; octß1r/
transheterozygoteshave increasednumberof natural synaptopods, indicatingagenetic interaction [N (left to right)175, 21, 11,
10, 11 NMJs]. J, Quantification of type II boutons at muscle 12 in animals of the same genotypes in I, showing that octß1r/;
go007/ transheterozygotes have increased number of type II boutons, indicating a genetic interaction [N (left to right) 22,
15, 16, 12, 16 NMJs]. Scale bar, 12m. Error bars indicate SEM. ***p 0.0001; **p 0.001; *p 0.05.
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expressing PTX or the two Go-RNAi constructs in octopamin-
ergic neurons resulted in significant increase in the number of
type II boutons (Fig. 3H). To further test the hypothesis that
Octß1Rmediates inhibition via Go, we also looked for evidence
of genetic interactions between octß1r and go genes. Heterozy-
gotes go007/ (homozygous lethal) or octß1r/ showed no dif-
ferences in the number of natural synaptopods or type II boutons
(Fig. 3 I, J). However, in transheterozygotes ( go007/; octß1r/
), both the number of natural synaptopods and type II boutons
were significantly increased (Fig. 3 I, J). This nonadditive effect is
a strong indication that both genes act in the same pathway
(Anholt and Mackay, 2004; Greenspan, 2004). Together, these
results suggest that Octß1R receptors inhibit the growth of type II
endings via inhibitory G-protein Go.
Octß1R functions upstream of cAMP production and is
partially dependent on Octß2R function
Go functions by inhibiting cAMP production (Johnston and
Watts, 2003). Thus, we predicted that decreasing cAMP levels by
an independent approach should suppress the synaptic over-
growth phenotype in octß1rmutants. This hypothesis was tested
by examining synaptopod formation in animals also lacking the
adenylate cyclase, Rutabaga (Rut), or by overexpressing the phos-
phodiesterase, Dunce (Dnc), in the octß1r mutant background.
Consistent with this hypothesis, both conditions prevented the
increase in synaptopods elicited bymutations in octß1r (Fig. 4A).
Similarly, they also prevented the increase in the number of type
II boutons (Fig. 4B). Since the resulting phenotypes are no dif-
ferent from the phenotypes observed in the rut mutant alone or
upon overexpressing Dnc alone, it is likely that Rut and Dnc are
downstream components of the Octß1R pathway.
We previously demonstrated that Octß2R receptors promote
the formation of synaptopods and the expansion of type II termi-
nals by increasing cAMP production (Koon et al., 2011). How-
ever, other G-protein-coupled receptors, in addition to Octß2R
receptors,may also regulate cAMPproduction at octopaminergic
neurons. To determine whether Octß1R receptors function by
antagonizing the action of Octß2R receptors alone, other
G-protein-coupled receptors, or a combination of both, we gen-
erated octß1r, octß2r double mutants by recombining the muta-
tions on the third chromosome. The presence of the double
mutation was verified by genomic PCR. If Octß1R functions by
exclusively inhibitingOctß2R, then the octß1r, octß2r doublemu-
tant should not be different from octß2rmutants alone.However,
we found that, in the octß1r, octß2r doublemutant, the number of
natural synaptopods was significantly higher than that in the
octß2rmutant and similar to wild-type controls (Fig. 4C). Similar
results were obtained when counting the number of type II bou-
tons, which were significantly larger than octß2rmutants but not
significantly different from wild type (Fig. 4D). These observa-
tions suggest that Octß1R receptors function at least partially
through Octß2R receptors, but that they additionally inhibit an
alternative G-protein-coupled receptor during synaptopod for-
mation and type II terminal extension.
That the octß1r, octß2r double mutant was no different from
control suggests that the two receptors are not absolutely re-
quired for normal extension of synaptopods or proliferation of
type II boutons, but that, rather, they exert a modulatory role,
which may be relevant for physiological responses to stimuli.
Indeed, as described below, although the double mutant has a
normal number of synaptopods and type II boutons, it has im-
paired locomotion and abnormal response to starvation.
Acute octopamine- and cAMP-induced synaptic growth is
occluded in octß1rmutants
We also examined the effect of octopamine application on syn-
aptopod formation at type II endings in octß1r mutants and in
larvae expressing Go-RNAi, Gi-RNAi, or PTX in octopamin-
ergic neurons.No response to octopaminewas observed at type II
terminals in octß1r mutants, when Go was downregulated, or
when PTX was expressed throughout larval development in oc-
topaminergic neurons (Fig. 5A). In contrast, the response to oc-
topamine when Gi was downregulated was normal (Fig. 5A). A
likely explanation for the lack of response to octopamine in octß1r
mutants or when expressing either Go-RNAi or PTX, is our
observation that, in these conditions, the number of natural syn-
aptopods is substantially increased (Figs. 2A–C, 3D–G). It is pos-
sible that synaptopod formation has reached saturation in these
animals, whichwould occlude a further increase in the number of
synaptopods by octopamine application. This interpretation was
supported by studies of dnc mutants. dnc encodes a cAMP-
specific phosphodiesterase, and thus when mutated it results in
Figure 4. Suppression of the overgrowth phenotype of octß1r by decreasing cAMP. A, B,
Quantification of natural synaptopods per 100m of type II arbor (A) and type II boutons at
muscle 12 (B) in octß1rmutants, rutmutants, animals overexpressing Dnc in type II and com-
binations of these genetic manipulations, showing that rut and overexpressing Dnc fully sup-
press the synaptic overgrowth phenotype of octß1r, suggesting that Rut and Dnc are
downstream components of the Octß1R signaling pathway [N (left to right) 175, 21, 24, 13,
14, 13 NMJs in A; N (left to right) 22, 15, 18, 18, 12, 12 NMJs in B]. C, D, Quantification of
natural synaptopods per 100m of type II arbor (C) and type II boutons at muscle 12 (D) in
octß2rmutants, octß1rmutants, and octß1r, octß2r double mutants, showing that Octß1R and
Octß2R function partially independently [N (left to right) 175, 13, 21, 12 NMJs in C;N (left to
right)22, 17, 15, 16NMJs inD]. Error bars indicate SEM. ***p0.0001; **p0.001;
*p 0.05.
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significant increase in cAMP levels and consequently a drastic
increase in the number of natural synaptopods, likely to satura-
tion (Koon et al., 2011). As in the above strains, dncmutants did
not show any increase in the number of synaptopods in response
to octopamine (Fig. 5A).
To test whether the lack of response to octopamine in octß1r
mutants was due to occlusion resulting from saturating cAMP
levels, we induced a maximal increase in cAMP levels with fors-
kolin, which activates adenylate cyclases and increases intracellu-
lar cAMP, thus bypassing the activation of GPCRs by ligand
binding (Seamon et al., 1981). If cAMP levels are saturated, this
manipulation is expected not to further increase the number of
synaptopods in octß1r mutants. Forskolin at 10 M was bath
applied to control and octß1rmutant body wall muscle prepara-
tions. In control animals, forskolin resulted in an increase of
synaptopods similar to that produced by octopamine (Fig. 5B).
In contrast, no increase in synaptopod formationwas observed in
octß1rmutants (Fig. 5B).
Our previous studies demonstrated that octß2r mutants also
fail to respond to octopamine by forming new synaptopods,
which is similar to the findings above with octß1rmutants (Koon
et al., 2011). However, in contrast to octß1rmutants, octß2rmu-
tants responded normally to forskolin (Fig. 5B) and had an NMJ
undergrowth phenotype (Fig. 2C,F). Together, the above results
support the notion that the response to octopamine in octß1r
mutants is occluded due to saturating cAMP levels.
Octß1R is required for the increase in locomotion in response
to starvation
In our previous study, we demonstrated that Octß2R receptors are
necessary for octopamine-induced cAMP increase in type IImotor-
neurons and starvation-induced larval locomotor increase (Koon et
al., 2011). Since type II terminals of octß1rmutants also do not re-
spondtooctopamine,wewonderedwhether the increase in locomo-
tor activity upon starvationwould also be blocked in octß1rmutants
similar to octß2rmutants.Aswe expected, octß1r failed to respond to
starvation by increasing locomotor speed (Fig. 6A), possibly due to
high levels of cAMP hindering normal Octß2R-dependent cAMP
increase and as observed when dnc levels are reduced (Koon et al.,
2011). The same defect was also observed in animals expressing
UAS-PTXorGo-RNAi1 in octopaminergic neurons, but notGi-
RNAi1 (Fig. 6A). This result indicates that both inhibitory Octß1Rs
and excitatory Octß2Rs are required for normal starvation-induced
behavior in larva. It also confirms our previous findings that octo-
paminergic and cAMP-dependent signaling within octopaminergic
neurons is necessary for this type of behavioral plasticity. Interest-
ingly, octß1r, octß2rdoublemutantswere still defective in the starva-
tion response (Fig. 6A), even though they have wild-type levels of
natural synaptopods and boutons (Fig. 4C,D). These results suggest
that both Octß1R and Octß2R are required for proper locomotor
increase during starvation.Moreover, it is apparently not the endog-
enous amount of octopaminergic innervation that determines the
animals’ ability to increase locomotion during starvation. Instead, it
Figure 5. octß1rmutation or disruption of Go function likely results in saturating levels of
cAMP. A, Quantification of the net increase of synaptopods per 100 m of type II arbor in
response to exogenous octopamine application in octß1r mutants, dnc mutants, and animals
expressingPTX, Go-RNAi, or Gi-RNAi in type II, showing that bath applicationof octopamine
increases synaptopods in control and Gi-RNAi animals, but not in animals with disrupted
Octß1R or Go pathway, which have increased natural synaptopods [N (left to right) 14, 13,
12, 10, 10, 11, 12, 11, 19, 10 NMJs]. Animals used in RNAi experiments were reared at 29°C to
increase knockdown efficiency. B, Quantification of the net increase of synaptopods per 100
m of type II arbor in response to exogenous octopamine or forskolin application in octß1r
mutants and octß2r mutants, showing that bath application of octopamine fails to increase
synaptopods in both octß1r and octß2r, whereas bath application of forskolin increases synap-
topods in octß2r but not in octß1r. This indicates that the lack of response to octopamine in
octß1r is likely due to saturating levels of cAMP [N (left to right) 14, 13, 11, 10, 12, 13, 11, 13,
10 NMJs]. Error bars indicate SEM. ***p 0.0001; **p 0.001; *p 0.05.
Figure 6. Octß1R is required for starvation-induced locomotor increase.A, Quantification of
the percentage increase of larval crawling speed in response to 2h starvation in octß1rmutants,
octß2r mutants, octß1r, octß2r double mutants, and animals expressing PTX, Go-RNAi, or
Gi-RNAi in octopaminergic neurons, showing that the disruption of the Octß1R pathway
results in defects in the increase of locomotor activity in response to starvation [N (left to
right) 26, 16, 16, 15, 16, 16, 16, 16, 17, 13, 19, 16, 16, 17 animals]. B, Quantification of the
basal crawling speedof the samegenotypes inA, showing that thedefect starvation responseof
PTX-type II andGo-RNAi1-type II inA is not due to a defect in basal locomotor speed [N (left to
right) 31, 16, 18, 29, 16, 18, 20, 14, 17, 15, 20, 17, 16, 20 animals]. Animals used in RNAi
experiments were reared at 29°C to increase knockdown efficiency. Error bars indicate SEM.
***p 0.0001; **p 0.001; *p 0.05.
6318 • J. Neurosci., May 2, 2012 • 32(18):6312–6322 Koon and Budnik • Octopaminergic Control of Synaptic Plasticity
seems likely that it is the capability of in-
creasing octopaminergic innervation and
cAMP levels in response to octopamine
during starvation that regulates this type of
behavioral change. However, since our ma-
nipulations involved the entire complement
of octopaminergic neurons, and not octo-
paminergic motorneurons alone, whether
all effects are directly due to type II innerva-
tion of the NMJ, or to a more central octo-
pamine function in the brain, remains to be
established.
It is also possible that the lack of behav-
ioral response to starvation is due to de-
fects in basal levels of locomotion in the
above genotypes. Thus, we compared the
basal larval locomotor speed in these ani-
mals. We found that octß1r mutants in-
deed had a decreased basal locomotor
activity (Fig. 6B). Nevertheless, this defect
was not observed in animals expressing
PTX or Go-RNAi1 in octopamine neu-
rons, indicating that, at least in these ge-
notypes, their starvation response defect
is unlikely a secondary effect of a basal al-
teration in locomotion (Fig. 6B).
Octß1R receptors inhibit type I
synaptic growth in a
cell-autonomous manner
We previously demonstrated that block-
ing octopamine synthesis by amutation in
tyramine-ß-hydroxylase (tbh), the gene
encoding the octopamine biosynthetic
enzyme, or octopamine release by ablat-
ing type II endings, results in a decrease in
the growth of type I boutons, implicating
type II endings in regulating the plasticity
of type I terminals (Koon et al., 2011).
This effect was mediated by the function
of Octß2R receptors in type I motorneu-
rons. Thus, we wondered whether
Octß1R receptors, in addition to antago-
nizing the effects of Octß2R receptors in
octopaminergic neurons, could also an-
tagonize the growth of type I boutons in a
cell-autonomous fashion. Indeed, as pre-
dicted, mutations in octß1r led to a signif-
icant increase in the number of type I
boutons (Fig. 7A,B,E). Similarly, an in-
crease in the number of type I boutons
was also observed in go007/; octß1r/
transheterozygotes (Fig. 7E) again, sup-
porting a genetic interaction between
octß1r and go. Furthermore, expressing
PTX, downregulating Octß1R or Go in
type I motorneurons alone, using BG439-
Gal4, or simultaneously in type I and type
II motorneurons, using C380-Gal4, led to
a significant increase in the number of
type I boutons (Fig. 7C,D,F,G). In con-
trast, the same genetic manipulations in
octopamine neurons alone did not result
Figure 7. Octß1R negatively regulates type I synaptic growth in a cell-autonomous manner. A–D, Third-instar larval NMJs at
muscles 6/7 of wild type (A), octß1rmutant (B), Go-RNAi1/ control (reared at 29°C) (C), and Go-RNAi1-type III (reared at
29°C) (D), showing a marked increase in the number of type I boutons. NMJs were labeled with anti-HRP. The panels represent
confocal Z-stack projections. E, Quantification of type I boutons at muscle 6/7 in octß1r mutants, octß1r/ heterozygotes,
go007/ heterozygotes, and go007/; octß1r/ transheterozygotes, showing that octß1r mutants and go007/;
octß1r/ transheterozygotes have increased number of type I boutons [N (left to right) 18, 15, 16, 16, 12, 18 NMJs]. F–H,
Quantification of type I boutons atmuscle 6/7 in animals expressing PTX, Octß1R-RNAi, Go-RNAi, or Gi-RNAi in type I and type
II (F ), type I (G), and type II (H ), showing that the disruption Octß1R or Go in type I and type II simultaneously or type I alone
increase type I boutons [N (left to right) 18, 14, 14, 16, 15, 12, 14, 12, 12, 16, 12, 16, 14, 16 NMJs in F;N (left to right) 18, 12,
16, 15, 13, 18, 12, 10, 12, 13 NMJs in G; N (left to right) 18, 12, 14, 15, 11, 12, 16, 16, 10, 16 NMJs]. Animals used in RNAi
experiments were reared at 29°C to increase knockdown efficiency. Scale bar: A–D, 10m. Error bars indicate SEM. ***p
0.0001; **p 0.001; *p 0.05.
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in any change in the expansion of type I boutons (Fig. 7H), and
downregulation of Gi in type I and/or type II also had no effect
(Fig. 7F–H). These results suggest that Octß1R receptors and
Go regulate the growth of type I terminals in a cell-autonomous
fashion, similar to that in type II.
Discussion
We previously demonstrated that octopamine regulates synaptic
and behavioral plasticity through an autoregulatory positive-
feedback mechanism involving Octß2R, which promotes both
type I and type II outgrowth (Koon et al., 2011). We have now
identified an octopamine receptor, Octß1R, which antagonizes
the function of Octß2R. We propose that Octß1R may serve as a
brake for the positive feedback induced by Octß2R. We demon-
strated that Octß1R receptors inhibit the cAMP pathway via the
inhibitory G-protein Go, as loss of Octß1R or Go function
results in synaptic overgrowth of type I and type II endings in an
octopamine cell-autonomous manner, and as octß1r and go in-
teract genetically. Notably, defective Octß1R signaling appears to
saturate cAMP levels, occluding the function of Octß2R. Thus,
the loss of Octß1R function results in insensitivity to octopamine
stimulation. In turn, this abolishes starvation-induced behavioral
changes that require Octß2R signaling. While in this study we
centered primarily on Octß1R function at octopaminergic NMJ
terminals, it is important to emphasize that octopamine neurons
are also present in the larval brain. Thus, with current tools we
cannot discern whether the defects are exclusively due to the
function of octopaminergic motorneurons, or whether other
central octopaminergic neurons contribute to these effects.
While the phenotypes on NMJ development are most parsimo-
niously explained by a local function at NMJ terminals, it is likely
that the behavioral effects are more complex, also involving im-
portant contribution from brain octopaminergic neurons.
At the Drosophila larval NMJ, three type II motorneurons
innervate most of the body wall muscles in each segment (Koon
et al., 2011). This layout suggests that octopamine is likely to
globally regulate plasticity, by tuning the excitability levels of
multiple excitatory synapses on the body wall muscles. Together,
the observations in our previous study (Koon et al., 2011) and
this investigation identify the presence of excitatory and inhibi-
tory octopamine receptors that are coexpressed in the same cells.
This suggests that global regulation of synapses and behavior by
octopamine can be tipped toward excitation or inhibition de-
pending on receptor expression levels, affinity of the receptors for
octopamine, and availability of these receptors for binding octo-
pamine on the target cells. This dual mode of controlling excit-
ability likely provides enhanced flexibility, allowing a broader
level of control over synaptic functions.
An important question is how can Octß1R and Octß2R regu-
late development of innervation and behavior given that they are
activated by the same ligand, are localized in the same cells, and
their functions are antagonistic. Several alternatives can be pro-
posed. Octß1R and Octß2R might have different affinities for
octopamine binding. Thus, different levels of octopamine release
could differentially activate the receptors. For instance, if Octß1R
receptors have higher affinity for octopamine, and octopamine is
normally released at low levels, a stable degree of innervation
could be maintained by continuous inhibition of synaptic
growth-promoting signals. High levels of octopamine release, as
would occur during starvation (Davenport and Evans, 1981),
would then activate the lower affinity Octß2R, eliciting synaptic
growth. Precedence for this type of regulation has been obtained
in honeybees and olive fruit flies, where low concentrations of
octopamine are inhibitory while high concentrations are excit-
atory to cardiac contraction (Papaefthimiou and Theophilidis,
2011).
An alternative possibility is based on the well known inter-
nalization of GPCRs upon ligand binding (Calebiro et al.,
2010). It is possible that such a mechanism would maintain an
appropriate ratio of Octß1R and Octß2R at the cell surface,
actively keeping or removing octopamine receptor-mediated
excitation or inhibition, depending on physiological states. A
third alternative is that receptors could be posttranslationally
modified upon ligand binding, which might also affect their
downstream functions. For example, dimerization of ß2-
adrenergic receptors can inhibit its adenylate cyclase-activating
activity (Hebert et al., 1996) and phosphorylation of ß1-
adrenergic receptor by PKA reduces its affinity for Gs and in-
creases its affinity for Gi/o (Martin et al., 2004). Last, Octß1R
and Octß2R receptors could be spatially separated in neurons,
with one receptor being closer and the other distant to sites of
octopamine release. In this scenario, the receptors would likely be
exposed to different octopamine concentration.
Simultaneous expression of excitatory and inhibitory GPCRs
in the same neuron has been reported previously. For instance,
mammalian dopamine receptors can couple to both stimulatory
and inhibitory G-proteins, with the D1 receptor-like family being
coupled to Gs and the D2-like family being coupled to Gi/o
(Beaulieu and Gainetdinov, 2011).
Previous studies have investigated the effect of octopamine on
synaptic transmission at the Drosophila first-instar (Nishikawa
and Kidokoro, 1999) and third-instar (Kutsukake et al., 2000;
Nagaya et al., 2002; Koon et al., 2011) larval NMJ. While the
studies at the third-instar larval NMJ demonstrated an excitatory
effect of octopamine in neurotransmission (Kutsukake et al.,
2000; Nagaya et al., 2002; Koon et al., 2011), the study on the
first-instar larval stage substantiated an inhibitory effect (Ni-
shikawa and Kidokoro, 1999). A recent study now provides a
potential explanation for such discrepancy between the responses
to octopamine at the two larval stages (Ohhara et al., 2012). In
particular, it was found that that Octß1R is expressed at high
levels in first instar and at low levels in third instar. In contrast,
Octß2R is expressed at low levels in first instar and at high levels
in third instar (Ohhara et al., 2012). Our studies demonstrating
an inhibitory role for Octß1R (this study) and an excitatory role
forOctß2R (Koon et al., 2011) are in agreementwith the idea that
octopaminemay play an inhibitory role during first instar, but an
excitatory role during third instar.
Octopamine receptors have been shown to elicit intracellular
Ca2 and/or cAMP increase (Han et al., 1998; Balfanz et al.,
2005). OAMB, the only-adrenergic-like receptor inDrosophila,
has been implicated to function via Ca2 signaling in the Dro-
sophila oviduct (Lee et al., 2009).However,OAMB is expressed in
the oviduct epithelium, andnot in the oviductmuscle cells (Lee et
al., 2009). Given that octopamine induces relaxation of oviduct
muscles, the presence of an alternative, inhibitory octopamine
receptor in oviduct muscles was proposed (Lee et al., 2009). Our
identification of Octß1R receptor as an inhibitory receptor raises
the possibility that this is the inhibitory receptor in the oviduct.
In apparent contradiction to our findings, a previous study
has shown that Octß1R (also known as OA2) is capable of in-
creasing cAMP (Balfanz et al., 2005). In this study, HEK293 cells
transfected with Octß1R were exposed to different octopamine
concentrations, which resulted in an increase in cAMP levels
(Balfanz et al., 2005). A potential explanation for the disparate
results is that GPCR overexpression might alter its coupling to
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downstream pathways. For instance, mammalian ß2-adrenergic
receptors are known to couple to both Gs and Gi/o proteins
(Xiao, 2001). However, overexpression of ß2-adrenergic recep-
tors constitutively couples the receptor to Gs and not to Gi or
Go (Milano et al., 1994; Bond et al., 1995). Furthermore, anal-
ysis of its binding specificity through immunoprecipitation
shows that, when the receptor was overexpressed in transgenic
mice, it coprecipitated with Gs but not with Gi/o in the ab-
sence of agonist (Gurdal et al., 1997). An additional explanation
is that human embryonic kidney HEK293 cells are unlikely to
express the same transduction pathways as endogenousDrosoph-
ila cells. Indeed, a recent study showed that HEK293 cells express
virtually no Go (Atwood et al., 2011), which could also explain
the lack of inhibitory response of overexpressed Octß1R in this
cell line.
Go is expressed in the nervous system of Drosophila and
shows a marked increase in levels during the development of
axonal tracts (Guille´n et al., 1991). Go levels are altered inmem-
ory mutants including dunce and rutabaga (Guille´n et al., 1990),
and Go is necessary for associative learning (Ferris et al., 2006).
PTX overexpression in mushroom bodies of adult Drosophila
severely disruptsmemory (Ferris et al., 2006), suggesting a role of
Go in synaptic plasticity. However, homozygous go mutants
are lethal due to defective development of the heart (Fre´mion et
al., 1999) preventing the use of nullmutants in studies of theNMJ
or the adult brain. Moreover, overexpression of inhibitory
G-proteins is known to sequester available Gß and G subunits,
resulting in unspecific downregulation of other G-protein signal-
ing (Katanayeva et al., 2010). Thus, there are significant problems
associated with the use of an overexpression approach to study
Go function. Fortunately, the availability of PTX and multiple
Go-RNAi strains allowed us to downregulate Go function in a
cell-specific manner to examine synaptic development at the
NMJ, which was found to phenocopy defects observed at the
NMJ of octß1rmutants. The presence of genetic interactions be-
tween the octß1r and go genes further support the notion that
the two proteins act in the same signaling pathway to inhibit
synaptic growth. These results provide strong evidence for the
involvement of Go in synaptic plasticity at the NMJ.
In summary, our studies reveal that octopamine acts both as
an inhibitory and excitatory transmitter to regulate synaptic
growth and behavior. Thus, the inhibitory function of octo-
pamine in global synaptic growth is as crucial as its excitatory
function in maintaining plasticity in a dynamic range.
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